
News|Articles|July 1, 2003
Atomoxetine displays long-term efficacy in adult patients with ADHD
Long-term treatment of 384 adults ADHD patients with atomoxetine (Strattera, Lilly) showed that 67% responded with at least a 30% improvement and 40% had at least a 50% improvement.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
3
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
4
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
5


























